(ICL) ICL Israel Chemicals - Ratings and Ratios
Exchange: NYSE • Country: Israel • Currency: USD • Type: Common Stock • ISIN: IL0002810146
ICL: Potash, Phosphate, Bromine, Magnesium, Fertilizers
ICL Group Ltd is a global leader in specialty minerals and chemicals, operating across four core segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment specializes in bromine-based compounds, derived as a by-product of potash production, along with salt, magnesium chloride, and magnesia products. It also produces phosphorous-based flame retardants used in fire safety applications. The Potash segment focuses on potash production, a critical ingredient in fertilizers, alongside salt, magnesium, and related by-products such as chlorine and sylvinite. The Phosphate Solutions segment leverages phosphate commodities to create specialty products, including fertilizers, sulphuric and green phosphoric acid, and phosphate salts. This segment also develops functional food ingredients and additives. The Growing Solutions segment offers a wide range of fertilizers, including water-soluble, controlled-release, and bio-stimulants, catering to agricultural needs. Additionally, ICL provides digital platforms and technological solutions for precision agriculture.
The company serves a diverse array of industries, including agriculture, food, pharmaceuticals, oil and gas, construction, electronics, automotive, and healthcare. Its products are distributed globally through a network of marketing companies, agents, and distributors. ICL Group Ltd, formerly known as Israel Chemicals Ltd, was incorporated in 1968 and is headquartered in Tel Aviv, Israel. The company rebranded as ICL Group Ltd in May 2020 to reflect its expanded global operations and diversified product portfolio.
Based on the provided data, here is the 3-month forecast:
Overall, ICL is anticipated to experience steady growth over the next three months, driven by its diversified product portfolio and strong market demand. The stock is likely to trade within a range of $6.40 to $6.80, with potential upside driven by positive earnings surprises or increased demand for its agricultural solutions.
Additional Sources for ICL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ICL Stock Overview
Market Cap in USD | 8,762m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception | 2014-09-24 |
ICL Stock Ratings
Growth Rating | 51.5 |
Fundamental | 8.42 |
Dividend Rating | 57.5 |
Rel. Strength | 55.3 |
Analysts | 2.8/5 |
Fair Price Momentum | 6.98 USD |
Fair Price DCF | 11.01 USD |
ICL Dividends
Dividend Yield 12m | 3.31% |
Yield on Cost 5y | 7.63% |
Annual Growth 5y | 16.33% |
Payout Consistency | 67.0% |
ICL Growth Ratios
Growth Correlation 3m | 49.8% |
Growth Correlation 12m | 71.5% |
Growth Correlation 5y | 15.8% |
CAGR 5y | 22.56% |
CAGR/Max DD 5y | 0.36 |
Sharpe Ratio 12m | 0.40 |
Alpha | 37.10 |
Beta | 0.912 |
Volatility | 34.46% |
Current Volume | 594.1k |
Average Volume 20d | 660.2k |
As of May 10, 2025, the stock is trading at USD 6.84 with a total of 594,138 shares traded.
Over the past week, the price has changed by +2.24%, over one month by +20.85%, over three months by +13.61% and over the past year by +47.18%.
Neither. Based on ValueRay Fundamental Analyses, ICL Israel Chemicals is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.42 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ICL as of May 2025 is 6.98. This means that ICL is currently overvalued and has a potential downside of 2.05%.
ICL Israel Chemicals has received a consensus analysts rating of 2.80. Therefor, it is recommend to hold ICL.
- Strong Buy: 0
- Buy: 0
- Hold: 4
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, ICL ICL Israel Chemicals will be worth about 7.7 in May 2026. The stock is currently trading at 6.84. This means that the stock has a potential upside of +12.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 6.1 | -11.1% |
Analysts Target Price | 4.8 | -30.1% |
ValueRay Target Price | 7.7 | 12.9% |